Crowdonomics
All companies
Fluo Labs logo

Fluo Labs

Operating

Fluo Labs, Inc.

Biotech · Biotech · Founded 2020

A breakthrough in allergy symptom relief

Post-money valuation ⓘ
$1.3M
As of Oct 2021 · from Reg CF Offering (2021) · pre-money + amount raised, not a traded price
Total raised
$1,488,740
Crowd $0 · Private $1.5M · 2 rounds since 2020
Latest share price
$1.00
Reg CF · Common Stock · Jun 2021 offering price

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$0
2019
$0
−$220K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited
FY2020 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$220,043
Taxes paid
$0
$800
Balance sheet
Cash
$0
$1,131
Accounts receivable
$0
$0
Total assets
$0
$234,202
Short-term debt
$0
$165,505
Long-term debt
$0
$68,697
Total liabilities
$0
$234,202
Other
Headcount
—
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$1.2M
pre-money
Reg CF · Common · Jun 2021

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

log scale
$1.00$0.1673$0.028
Apr 2020Jun 2021
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Reg CF · Common Stock · Jun 2021Withdrawnvia StartEngine
Raised $82.3K / $3.8MInvestors 109Post-money $1.3M

Team

1 person
Lawrence Johnson
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

109 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-WOct 28, 20210001665160-21-001908
    EDGAR
  • Form CJun 23, 20210001665160-21-001165
    EDGAR
Source: ManualCIK 0001868310Share price $1.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.